4//SEC Filing
BioDiscovery 4 FCPR 4
Accession 0001562180-19-005751
CIK 0001603756other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 9:07 PM ET
Size
7.2 KB
Accession
0001562180-19-005751
Insider Transaction Report
Form 4
BioDiscovery 4 FCPR
10% Owner
Transactions
- Sale
Common Stock
2019-11-22$20.73/sh−300,000$6,220,500→ 3,257,461 total(indirect: See footnote)
Andera Partners
10% Owner
Transactions
- Sale
Common Stock
2019-11-22$20.73/sh−300,000$6,220,500→ 3,257,461 total(indirect: See footnote)
Footnotes (2)
- [F1]The shares were sold in a public offering pursuant to the Registration Statement of Axonics Modulation Technologies, Inc. on Form S-3 (File No. 333-234546)
- [F2]2,524,128 shares are held of record by BioDiscovery 4 FCPR ("BioDiscovery") and 733,333 shares are held of record by BioDiscovery 5 ("BioDiscovery 5"). Andera Partners ("Andera") is the manager of BioDiscovery and BioDiscovery 5 and may be deemed to have sole voting and dispositive power over the shares held by BioDiscovery and BioDiscovery 5.
Documents
Issuer
Axonics Modulation Technologies, Inc.
CIK 0001603756
Entity typeother
IncorporatedFrance
Related Parties
1- filerCIK 0001756321
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 9:07 PM ET
- Size
- 7.2 KB